|
Name |
7,9-Di-tert-butyl-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione
|
Molecular Formula | C17H24O3 | |
IUPAC Name* |
7,9-ditert-butyl-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione
|
|
SMILES |
CC(C)(C)C1=CC2(CCC(=O)O2)C=C(C1=O)C(C)(C)C
|
|
InChI |
InChI=1S/C17H24O3/c1-15(2,3)11-9-17(8-7-13(18)20-17)10-12(14(11)19)16(4,5)6/h9-10H,7-8H2,1-6H3
|
|
InChIKey |
ZTMZUYHXZPUDRF-UHFFFAOYSA-N
|
|
Synonyms |
82304-66-3; 7,9-Di-tert-butyl-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione; 7,9-ditert-butyl-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione; 7,9-Di-tert-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dione; 7,9-Di-tert-butyl-1-oxaspiro[4,5]deca-6,9-diene-2,8-dione; 1-Oxa-spiro[4.5]deca-6,9-diene-2,8-dione, 7,9-di-tert-butyl-; 1-Oxaspiro[4.5]deca-6,9-diene-2,8-dione, 7,9-bis(1,1-dimethylethyl)-; SCHEMBL13571242; CHEBI:88174; DTXSID60337884; 7,9-Di-tert-butyl-1-oxa-spiro[4.5]deca-6,9-diene-2,8-dione; BCP25537; MFCD00733511; AS-70063; CS-0188444; D92996; EN300-18561100; Q27160100; Z3244812485; 7,9-di-t-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dione; 7,9-ditert-butyl-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione;7,9-Bis(1,1-dimethylethyl)-1-oxaspiro[4.5]deca-6,9-diene-2,8-dione
|
|
CAS | 82304-66-3 | |
PubChem CID | 545303 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 276.4 | ALogp: | 3.8 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 43.4 | Aromatic Rings: | 2 |
Heavy Atoms: | 20 | QED Weighted: | 0.619 |
Caco-2 Permeability: | -4.646 | MDCK Permeability: | 0.00001820 |
Pgp-inhibitor: | 0.966 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.024 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.083 | Plasma Protein Binding (PPB): | 91.87% |
Volume Distribution (VD): | 1.007 | Fu: | 15.55% |
CYP1A2-inhibitor: | 0.594 | CYP1A2-substrate: | 0.138 |
CYP2C19-inhibitor: | 0.862 | CYP2C19-substrate: | 0.6 |
CYP2C9-inhibitor: | 0.849 | CYP2C9-substrate: | 0.58 |
CYP2D6-inhibitor: | 0.885 | CYP2D6-substrate: | 0.258 |
CYP3A4-inhibitor: | 0.663 | CYP3A4-substrate: | 0.465 |
Clearance (CL): | 4.681 | Half-life (T1/2): | 0.694 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.414 |
Drug-inuced Liver Injury (DILI): | 0.199 | AMES Toxicity: | 0.049 |
Rat Oral Acute Toxicity: | 0.706 | Maximum Recommended Daily Dose: | 0.767 |
Skin Sensitization: | 0.551 | Carcinogencity: | 0.906 |
Eye Corrosion: | 0.047 | Eye Irritation: | 0.143 |
Respiratory Toxicity: | 0.839 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000452 | 0.533 | D0W7WC | 0.238 | ||||
ENC000513 | 0.484 | D01JFT | 0.219 | ||||
ENC000811 | 0.462 | D0Y4DY | 0.217 | ||||
ENC000730 | 0.460 | D0K7LU | 0.217 | ||||
ENC001383 | 0.394 | D0C7JF | 0.213 | ||||
ENC001382 | 0.333 | D0L7AS | 0.212 | ||||
ENC000708 | 0.319 | D09EBS | 0.198 | ||||
ENC000079 | 0.314 | D00IUG | 0.196 | ||||
ENC000725 | 0.314 | D03GCJ | 0.196 | ||||
ENC000346 | 0.314 | D0M6DO | 0.193 |